Navigation Links
Researchers and Patient Advocates Honored with PhRMA Award
Date:9/7/2012

WASHINGTON, Sept. 7, 2012 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year's award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care for Alzheimer's disease.

"Too often, the hard work and unwavering commitment by individuals who dedicate their lives to improving patient care go unrecognized. The Research and Hope Award honors those who rightly deserve credit for all of the sacrifices they have made to advance research and patient care in the fight against Alzheimer's disease," said PhRMA President and CEO John J. Castellani. "Despite the tremendous hurdles, the recipients of the Award have shown us that progress is not only possible, it is happening every day. Their achievements give hope to all of us, especially to patients and their families."

Alzheimer's disease is a progressive brain disease that slowly destroys memory and thinking skills, affecting one in eight older Americans. Current projections show that by 2050, one American will develop the disease every 33 seconds, costing the U.S. health care system $1.1 trillion annually. During that time, Alzheimer's related Medicare spending alone will increase nearly 600 percent. These projections could change dramatically if a treatment were discovered to help delay the onset of Alzheimer's by five years. Such a treatment could help save Medicare and Medicaid $140 billion annually in 2030, and could save the U.S. health care system $447 billion annually by 2050, according to the Alzheimer's Association.

"On behalf of PhRMA and our member companies, we salute these award recipients for their heroic work to advance medical research and improve patient care," said John C. Lechleiter, PhD, chairman, president, and chief executive officer of Eli Lilly and Company and chairman of PhRMA.   "The individuals whom we honor with the Research and Hope Awards, through their achievements, highlight the importance of our collaborative efforts to bring forth new medicines that alleviate suffering, improve lives, and bring hope for people around the world."

The researcher awardees were chosen by a special committee of the PhRMA Foundation Board of Directors following a nominations process. The patient advocate recipients were selected by a committee consisting of representatives from PhRMA and the cohost organizations.

The nominations were reviewed and discussed at length and chosen by a group of individuals with extensive knowledge and experience in the science and patient advocacy fields. 

The full list of awardees is below:

The Research and Hope Award for Academic Research in Alzheimer's:

Bradley T. Hyman, MD, PhD
Professor of Neurology
Massachusetts General Hospital/Harvard Medical School

David Holtzman, MD
Andrew B. and Gretchen P. Jones Professor and Chairman
Department of Neurology, Washington University School of Medicine

The Research and Hope Award for Biopharmaceutical Industry Research in Alzheimer's: Merck BACE Team

Eric M. Parker, PhD
Senior Director and Neuroscience Site Lead, Merck

Andrew W. Stamford, PhD
Director, Discovery Chemistry, Merck

Matthew E. Kennedy, PhD
Associate Director, Neuroscience, Merck

Mark S. Forman, MD, PhD
Director, Clinical Research, Merck

Julie A. Stone, PhD
Senior Scientific Director, Merck

The Research and Hope Award for Patient Engagement:

Kate Maslow
Institute of Medicine
Keck Center

The Research & Hope Award for Volunteer Champion: 

Neha Chauhan 
AFA Teens for Alzheimer's Awareness

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.

Find PhRMA Online:

For information on how innovative medicines save lives, visit: http://www.innovation.org 
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org 
For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Researchers Set Record for Detecting Smallest Virus, Opening New Possibilities for Early Disease Detection
2. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
3. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
4. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
5. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
6. Researchers Evaluate Computer-based Treatment for People with Schizophrenia
7. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
8. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
11. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec 8, 2016 Research and Markets ... report to their offering. ... The global chromatography market to grow ... Global Chromatography Market 2016-2020, has been prepared based on an in-depth market ... and its growth prospects over the coming years. The report also includes ...
(Date:12/8/2016)... 8, 2016 According to ... by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), ... Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global ... has witnessed healthy growth during the last decade, ... of 4.3% between 2016 and 2021 to reach ...
(Date:12/8/2016)... 8, 2016  Agenovir Corporation, a company using ... therapeutics, today announced that it appointed Dirk ... a member of the board of directors. ... a deep background in both founding and building ... Agenovir, co-president of Chan Zuckerberg  Biohub and ...
Breaking Medicine Technology:
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... as possible. With this in mind, SIGVARIS has created a new line of ... during bed rest and provide the benefits of graduated compression when transitioning from ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... from offices headquartered in Jefferson County, is announcing the launch of a charity ... , The number of homeless women and children in Birmingham has grown steadily ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... families and business owners in and around central Kansas, is joining the Youth ... youth in the region. , Headquartered in Wichita, Youth Horizons works to empower ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to ... researcher at the Icahn School of Medicine at Mount Sinai has found. The ... when young children are exposed to secondhand marijuana smoke, measurable amounts of primary ...
Breaking Medicine News(10 mins):